Loading stock data…
Serina Therapeutics, Inc. (SER)
$2.73+0.04 (+1.49%)
Pre-Market$2.72-0.01 (-0.37%)· Last close Sep 4
Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Serina Therapeutics, Inc. in the Healthcare sector is trading at $2.50 with a market capitalization of $27M. Wall Street consensus targets $9.50 (2 analysts), implying a +280.0% move over the next 12 months. The stock is currently 57% below its 52-week high of $5.83, remaining 9.6% above its 200-day moving average. On fundamentals, Piotroski 1/9 flags weak fundamentals, Altman Z in the distress zone. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +280.0% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -$6.28M↓ | -$6.21M↑ | -$6.39M↓ | -$5.57M↑ | -$5.86M |
| Net Income | -$6.90M↓ | -$3.34M↑ | -$4.58M↑ | -$6.45M↓ | -$4.81M |
Peer Comparison
JNJUNHPFE
Fundamentals
Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252 (POZ-apomorphine), a POZ conjugate for the treatment of advanced Parkinson's disease that is in phase 1 ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$26.85M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-120.64%
Volume
Today's trading volume
14,840
